-
Gene therapy provides life-changing relief from hemophilia
11/19/2014
Gene therapy developed at St. Jude Children’s Research Hospital, University College London and the Royal Free Hospital has transformed life for 10 men with severe hemophilia B.
-
The power of phone calls for protecting the heart
11/03/2014
For childhood cancer survivors, regular heart checkups can save lives. Yet despite the potential benefits, many survivors fail to get recommended checkups on schedule.
-
Launching a three-pronged attack against Ewing sarcoma
10/23/2014
Scientists at St. Jude have discovered a promising new triple-drug therapy for Ewing sarcoma, a cancer of the bone and soft tissue.
-
Another reason for hope
09/10/2014
In a St. Jude-led study, researchers found new genetic changes that drive the development of a high-risk leukemia subtype known as Ph-like ALL, and showed that patients may benefit from treatment with drugs called tyrosine kinase inhibitors.
-
Unhealthy lifestyle dramatically boosts health risks for childhood cancer survivors
07/28/2014
Adult survivors of childhood cancer who don’t get enough exercise and eat an unhealthy diet more than double their chances of developing metabolic syndrome.
-
New leads on hushing the “voices” of schizophrenia
06/05/2014
A missing gene and the resulting slow connection between brain structures may leave individuals vulnerable to the “voices” that are a common symptom of schizophrenia.
-
Molecule acts as umpire to make tough life-or-death calls
05/20/2014
St. Jude scientists have just determined that after birth, the enzyme RIPK1 functions like an umpire in cells, making the tough calls necessary to balance competing signals that determine if cells live or die.
-
Broken DNA is bad for the brain
05/14/2014
DNA may be the cornerstone of life, but the molecule breaks all the time. To read DNA’s code or make more DNA, cells routinely nick and unwind the famous double helix using specialized enzymes. Free radicals and other stresses can also break DNA.
-
For brain tumor patients, age matters
04/06/2014
Scientists at St. Jude have more evidence that age matters when it comes to the devastating brain tumors called high-grade gliomas (HGGs).
-
Can adult cancer drugs beat a childhood brain tumor?
03/27/2014
New hope may be offered for children with aggressive medulloblastoma by a discovery from St. Jude involving a pair of drugs used to treat adult cancers.
-
Childhood cancer survivors face mounting health risks in midlife
03/17/2014
The latest results from the Childhood Cancer Survivor Study reinforce the importance of lifelong health care for adult survivors of childhood cancer.
-
Predicting the outcome when flu strikes
02/10/2014
We depend on the disease-fighting immune system to protect us from flu infections or to help us recover if we catch the virus. Now there is evidence the immune system can also help to predict which flu patients will develop severe symptoms and wind up in the hospital.
-
New twist discovered in Lou Gehrig’s disease
02/05/2014
ALS remains incurable, but new insight into its causes gives reason to hope. A research team revealed that mutations causing ALS have an unexpected toxic effect in human nerve cells.
-
St. Jude creates promising new antibiotics
01/27/2014
Antibiotic resistance is a growing global concern, especially in bacteria that cause serious diseases, such as tuberculosis (TB).
-
Study highlights resilience of young cancer patients
01/21/2014
Despite having life-threatening illnesses, children and teens with cancer were no more likely than their healthy peers to report symptoms of post-traumatic stress disorder (PTSD).
